Asset
Epinephrine
ARS Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06834165 | phase4 | recruiting | 2025-05-20 | 2027-04-01 | ARS Pharmaceuticals, Inc. | Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 214697 | NDA | ARS PHARMACEUTICALS OPERATIONS INC |
Marketed products (2)
- NEFFY
- NEFFY